Advertisement

Fertility-Sparing Surgery for Early-Stage Uterine Cervical Cancer

  • Elisa Moreno-Palacios
  • Claudia Blancafort
  • Maria Lombarte
  • Ignacio Zapardiel
Chapter

Abstract

Cervical cancer is the second most common gynecological cancer, and approximately 45% are diagnosed in women younger than 40 years. In Western societies, in which women tend to delay childbearing and cervical cancer incidence peaks within the third decade of life, fertility-sparing treatment options have become a major issue.

In recent years, radical trachelectomy with pelvic lymphadenectomy has become an option for young patients with early-stage minimally invasive cervical cancers (stages IB1 or less) who wish to conserve their uterus, in order to preserve their fertility. Multiple studies have demonstrated the safety and feasibility of radical trachelectomy, as well as acceptable obstetrical outcomes. The aim of this chapter is to answer the main issues on this topic, such as surgical techniques, patient selection, and oncological and obstetric outcomes, according to the evidence published to date.

Keywords

Fertility-sparing surgery Uterine cancer surgery and fertility sparing Early-stage uterine cervical cancer Cervical cancer Cervical cancer incidence 

References

  1. 1.
    Parkhurst JO, Vulimiri M. Cervical cancer and the global health agenda: insights from multiple policy-analysis frameworks. Glob Public Health. 2013;8(10):1093–108.CrossRefGoogle Scholar
  2. 2.
    Torre LA, Bray F, Siegel RL, Ferlay J, Lortet-tieulent J, Jemal A. Global cancer statistics, 2012. CA Cancer J Clin. 2015;65(2):87–108.CrossRefGoogle Scholar
  3. 3.
    Cuschieri KS, Whitley MJ, Cubie HA. Human papillomavirus type specific DNA and RNA persistence – implications for cervical disease progression and monitoring. J Med Virol. 2004;73(1):65–70.CrossRefGoogle Scholar
  4. 4.
    Edwards BK, Noone A-M, Mariotto AB, Simard EP, Boscoe FP, Henley SJ, et al. Annual report to the nation on the status of cancer, 1975–2010, featuring prevalence of comorbidity and impact on survival among persons with lung, colorectal, breast, or prostate cancer. Cancer. 2014;120(9):1290–314.CrossRefGoogle Scholar
  5. 5.
    Covens A, Rosen B, Murphy J, Laframboise S, AD DP, Lickrish G, Colgan T, Chapman W, Shaw P. Changes in the demographics and perioperative care of stage IA(2)/IB(1) cervical cancer over the past 16 years. Gynecol Oncol. 2001;81(2):133–7.CrossRefGoogle Scholar
  6. 6.
    Kim SM, Choi HS, Byun JS. Overall 5-year survival rate and prognostic factors in patients with stage IB and IIA cervical cancer treated by radical hysterectomy and pelvic lymph node dissection. Int J Gynecol Cancer. 2000;10(4):305–12.CrossRefGoogle Scholar
  7. 7.
    Dargent D, Burn JL, Roy M, La trachélectomie élargie (T.E.). Une alternative á l’hystérectomie radicale dans le traitment des cancers infiltrants développés sur la face externe du col úterin. J Obstet Gynecol. 1994;2:292–5.Google Scholar
  8. 8.
    Dargent D, Mathevet P. Schauta’s vaginal hysterectomy combined with laparoscopic lymphadenectomy. Baillière’s Clin Obstet Gynaecol. 1995;9(4):691–705.CrossRefGoogle Scholar
  9. 9.
    Smith JR, Boyle DC, Corless DJ, Ungar L, Lawson AD, Del Priore G, et al. Abdominal radical trachelectomy: a new surgical technique for the conservative management of cervical carcinoma. Br J Obstet Gynaecol. 1997;104(10):1196–200.CrossRefGoogle Scholar
  10. 10.
    Ungár L, Pálfalvi L, Hogg R, Siklós P, Boyle DCM, Del Priore G, et al. Abdominal radical trachelectomy: a fertility-preserving option for women with early cervical cancer. BJOG. 2005;112(3):366–9.CrossRefGoogle Scholar
  11. 11.
    Lee CL, Huang KG, Wang CJ, Yen CF, Lai CH. Laparoscopic radical trachelectomy for stage Ib1 cervical cancer. J Am Assoc Gynecol Laparosc. 2003;10(1):111–5.CrossRefGoogle Scholar
  12. 12.
    Burnett AF, Stone PJ, Duckworth LA, Roman JJ. Robotic radical trachelectomy for preservation of fertility in early cervical cancer : case series and description of technique. J Minim Invasive Gynecol. 2009;16(5):569–72.CrossRefGoogle Scholar
  13. 13.
    Beiner ME, Hauspy J, Rosen B, Murphy J, et al. Radical vaginal trachelectomy vs. radical hysterectomy for small early stage cervical cancer (CC): a matched case-control study. Gynecol Oncol. 2008;110(2):168–71.CrossRefGoogle Scholar
  14. 14.
    Xu L, Sun F-Q, Wang Z-H. Radical trachelectomy versus radical hysterectomy for the treatment of early cervical cancer (CC): a systematic review. Acta Obstet Gynecol Scand. 2011;90(11):1200–9.CrossRefGoogle Scholar
  15. 15.
    Bentivegna E, Gouy S, Maulard A, Chargari C, Leary A, Morice P. Oncological outcomes after fertility-sparing surgery for cervical cancer (CC): a systematic review. Lancet Oncol. 2016;17(6):e240–53.  https://doi.org/10.1016/S1470-2045(16)30032-8.CrossRefPubMedGoogle Scholar
  16. 16.
    Sato S, Itamochi H, Sugiyama T. Fertility-sparing surgery for uterine cervical cancer. Future Oncol. 2016;12(20):2345–55.  https://doi.org/10.2217/fon-2016-0260.CrossRefPubMedGoogle Scholar
  17. 17.
    Rob L, Skapa P, Robova H. Fertility-sparing surgery in patients with cervical cancer. Lancet Oncol. 2011;12(2):192–200.CrossRefGoogle Scholar
  18. 18.
    Bentivegna E, Maulard A, Pautier P, Chargari C, Gouy S, Morice P. Fertility results and pregnancy outcomes after conservative treatment of cervical cancer (CC): a systematic review of the literature. Fertil Steril. 2016;106(5):1195–211.CrossRefGoogle Scholar
  19. 19.
    Carter J, Sonoda Y, Chi DS, Raviv L, Abu-Rustum NR. Radical trachelectomy for cervical cancer (CC): postoperative physical and emotional adjustment concerns. Gynecol Oncol. 2008;111(1):151–7.CrossRefGoogle Scholar
  20. 20.
    Abbara S, Nikolic B, Pelage JP, Banovac F, Spies JB. Frequency and extent of uterine perfusion via ovarian arteries observed during uterine artery embolization for leiomyomas. AJR Am J Roentgenol. 2007;188(6):1558–63.CrossRefGoogle Scholar
  21. 21.
    Halaska MJ, Robova H, Pluta M, Rob L. The role of trachelectomy in cervical cancer. E Cancer Med Sci. 2015;9:506.Google Scholar
  22. 22.
    Chan J, Letourneau J, Salem W, Pelin Cil A, Chan S, Chen L, Rosen M. Sexual satisfaction and quality of life in survivors of localized cervical and ovarian cancers following fertility-sparing surgery. Original Research Article. Gynecol Oncol. 2015;139(1):141–7.CrossRefGoogle Scholar
  23. 23.
    Carter J, Sonoda Y, Chi DS, Raviv L, Abu-Rustum NR. Radical trachelectomy for cervical cancer (CC): postoperative physical and emotional adjustment concerns. Gynecol Oncol. 2008;111:151–7.CrossRefGoogle Scholar
  24. 24.
    Pluta M, Rob L, Charvat M, Chmel R, Halaska M, Skapa P, et al. Less radical surgery than radical hysterectomy in early stage cervical cancer – a pilot study. Gynecol Oncol. 2009;113(2):181–4.CrossRefGoogle Scholar
  25. 25.
    Reade CJ, Eiriksson LR, Covens A. Surgery for early stage cervical cancer (CC): how radical should it be? Gynecol Oncol. 2013;131(1):222–30.CrossRefGoogle Scholar
  26. 26.
    Ramirez PT, Pareja R, Rendón GJ, Millan C, Frumovitz M, Schmeler KM. Management of low-risk early-stage cervical cancer (CC): should conization, simple trachelectomy, or simple hysterectomy replace radical surgery as the new standard of care? Gynecol Oncol. 2014;132(1):254–9.CrossRefGoogle Scholar
  27. 27.
    Robova H, Halaska M, Pluta M, Skapa P, Strnad P, Lisy J, et al. The role of neoadjuvant chemotherapy and surgery in cervical cancer. Int J Gynecol Cancer. 2010;20:S42–6.CrossRefGoogle Scholar
  28. 28.
    Robova H, Rob L, Halaska MJ, Pluta M, Skapa P, Strnad P, et al. High-dose density neo-adjuvant chemotherapy in bulky IB cervical cancer. Gynecol Oncol. 2013;128:49–53.CrossRefGoogle Scholar
  29. 29.
    Benedetti-Panici P, Greggi S, Colombo A, Amoroso M, Smaniotto D, Giannarelli D, et al. Neoadjuvant chemotherapy and radical surgery versus exclusive radiotherapy in locally advanced squamous cell cervical cancer (CC): result from the Italian multicenter randomized study. J Clin Oncol. 2002;20(1):179–88.CrossRefGoogle Scholar
  30. 30.
    Tomao F, Corrado G, Peccatori FA, Boveri S, Preti E, Colombo N, Landoni F. Fertility-sparing options in young women with cervical cancer. Curr Treat Options Oncol. 2016;17(1):5.  https://doi.org/10.1007/s11864-015-0386-9.CrossRefPubMedGoogle Scholar
  31. 31.
    Robova H, Halaska M, Pluta M, Skapa P, Matecha J, Lisy J, Rob L. Oncological and pregnancy outcomes after high-dose density neoadjuvant chemotherapy and fertility-sparing surgery in cervical cancer. Original Research Article. Gynecol Oncol. 2014;135(2):213–6.CrossRefGoogle Scholar
  32. 32.
    Brännström M, Dahm-Kähler P, Enskog A, Johannesson L, Lundmark C, Olausson M, et al. Transplantation of the uterus still at the experimental stage. Lakartidningen. 2014;111(18–19):806–7.PubMedGoogle Scholar
  33. 33.
    Johannesson L, Kvarnström N, Mölne J, Dahm-Kähler P, Enskog A, Diaz-Garcia C, et al. Uterus transplantation trial: 1-year outcome. Fertil Steril. 2015;103(1):199–204.CrossRefGoogle Scholar
  34. 34.
    Brännström M, Johannesson L, Bokström H, Kvarnström N, Mölne J, Dahm-Kähler P, et al. Livebirth after uterus transplantation. Lancet. 2015;385(9968):607–16.CrossRefGoogle Scholar
  35. 35.
    Pecorelli S. Revised FIGO staging for carcinoma of the vulva, cervix, and endometrium. Int J Gynaecol Obstet. 2009;105(2):103–4.CrossRefGoogle Scholar

Copyright information

© Springer Nature Switzerland AG 2019

Authors and Affiliations

  • Elisa Moreno-Palacios
    • 1
  • Claudia Blancafort
    • 2
  • Maria Lombarte
    • 3
  • Ignacio Zapardiel
    • 4
  1. 1.Department of GynecologyHospital Universitario La PazMadridSpain
  2. 2.Department of GynecologyHospital Universitari Quiron-DexeusBarcelonaSpain
  3. 3.Gynecologic Oncology UnitLa Paz University HospitalMadridSpain
  4. 4.Gynecologic Oncology UnitLa Paz University Hospital-IdiPAZMadridSpain

Personalised recommendations